Skip to main content
. 2022 Jan 6;12(1):63. doi: 10.3390/jpm12010063

Table 1.

Demographic data based on nodule volume.

Total Small
(≤10 mL)
Medium
(11–30 mL)
Large (>30 mL) p-Value
Number of patients 762 299 290 173
Number of nodules 826 351 295 180
Age Median 45.22 ± 11.97 44.44 ± 11.35 44.83 ± 12.60 47.40 ± 11.91 0.388
Sex, female/male 625 (82%)/137 (18%) 251/61 236/45 138/31 0.203
Laboratory studies
(mean ± SD)
Serum Free T4 (ng/dL) 1.17 ± 0.24 1.15 ± 0.20 1.19 ± 0.23 1.21 ± 0.31 0.140
Serum T3 (ng/dL) 105.58 ± 29.29 108.45 ± 30.65 101.80 ± 27.33 106.05 ± 29.20 0.045
Serum TSH (uIU/mL) 1.57 ± 1.19 1.79 ± 1.42 1.44 ± 1.01 1.37 ± 0.96 0.015
Technical characteristics
Delivered energy (Kcal) 7.92 ± 7.30 2.64 ± 2.06 7.08 ± 4.68 14.14 ± 8.20 <0.001
Energy/mL a (Kcal/cm3) 0.51 ± 0.32 0.69 ± 0.53 0.38 ± 0.24 0.24 ± 0.12 <0.001
Ablation time (minutes) 17.73 ± 9.68 10.09 ± 5.19 17.88 ± 7.25 25.34 ± 9.28 <0.001

a Energy/mL: energy delivered per milliliter of the pretreatment nodule volume. SD: standard deviation; ng: nanogram; dL: deciliter; uIU: mirco International Unit; kilocalorie; mL: milliliter; cm: centimeter.